Was it all a dream? Understanding sleep’s role in mediating psychiatric management in a rural outpatient setting 

Individuals with posttraumatic stress disorder (PTSD) commonly experience sleep disturbance. Such disturbances can have a birdrectional effect in those with PTSD –interrupted sleep due to hypervigilance and nightmares are common symptoms of PTSD, and poor sleep is associated with a worse course of PTSD. Sleep disturbance can potentially be a prognostic factor in overall outcome […]

Development of a task to measure the impact of PTSD symptoms on cognitive control and physiologic endpoints in response to interpersonal stressors

Posttraumatic stress disorder (PTSD) is linked to altered physiologic functioning, including increased blood pressure and heart rate, especially in response to stressors. Increased cardiovascular reactivity to trauma-related stressors may link PTSD to poorer cardiovascular health and thus an increased risk of cardiovascular disease. Prior work by our lab suggests that these effects of trauma may […]


Engagement patterns in pediatric integrated behavioral health: investigating service utilization and attrition among children with mental health and neurodevelopmental disorders

Children with comorbid mental health and neurodevelopmental disorders (NDDs) often require more intensive and coordinated care than those with mental health disorders alone. These two categories of disorders often present with comorbidity and engagement disparities in integrated behavioral health programs among this population remain poorly understood. This study examines differences in service utilization and attrition […]

Subtyping the neurobiology of PTSD through novel methods for the alpha- and beta-adrenergic autonomic nervous system components: a pilot study

Trauma and posttraumatic stress disorder (PTSD) are common in veteran and civilian populations. Meanwhile, observationally estimated half of people cared for at UW autonomic nervous system (ANS) disorder clinic have a history of trauma. Increasingly, research explains this observation through an evolving understanding of the complex interplay of peripheral and central catecholamine signaling that appear […]

Developing person-specific signatures of momentary risk for alcohol use

Alcohol use disorder remains a major public health concern, with persistent disparities in treatment outcomes. Traditional interventions often fail to account for the heterogeneity of drinking triggers, limiting their effectiveness. This study aims to develop and evaluate an idiographic, mobile-based clinical tool to identify personalized triggers for alcohol use. Idiographic methods allow for individualized assessments […]

From symptom relief to subtype identification: exploring patterns of cannabis use in PTSD

Post-traumatic stress disorder (PTSD) and substance use often go hand in hand, with many people using substances like cannabis to manage their symptoms. This concept, known as the self-medication hypothesis, suggests that people might use cannabis differently depending on the nature of their symptoms. Symptoms are classically split into domains – hyperarousal, emotional numbing, re-experiencing, […]

Improving risk-stratification of substance-induced psychosis: incorporating stakeholder perspectives and implementing a standardized assessment of risk factors

First-episode substance-induced psychosis (SIP) presents a clinical challenge in which treatment decisions cannot rely on evidence-based guidelines and long-term outcomes are not well understood. Preliminary findings from our retrospective study of psychiatry inpatients at Harborview Medical Center (HMC) suggest that patients with first-episode SIP had similar rehospitalization rates to those with first-episode psychosis (FEP) but […]

Unraveling the genetics of schizophrenia and bipolar disorder with large-language models

Schizophrenia (SCZ) and bipolar disorder (BPD) are among the most heritable psychiatric conditions, yet their genetic foundations remain poorly understood. Historically, unraveling these disorders’ genetic architectures was limited by inadequate technology. However, breakthroughs in next-generation sequencing have recently produced expansive genomic datasets—including those from the Psychiatric Genomics Consortium (PGC)—for SCZ and BD. Simultaneously, genomic foundation […]